Governance

Authority and accountability

Corporate governance rests with the Board of Directors, subject to the Articles of Incorporation and applicable law. The website's "Owner" role is a technical access role; it does not itself confer corporate ownership, a board seat, an officer appointment, or authority to override the Board. A published citation is not automatically a reviewed source. Scientific review, publication approval, promotion eligibility, and public promotion are recorded as distinct gates with provenance and an auditable decision history. Every required gate must pass for the exact source version. Unresolved issues are escalated for accountable adjudication.

Filed corporate structure

The Articles of Incorporation effective September 15, 2026 identify World Peptide Foundation as a nonmember, nonstock Arizona nonprofit corporation. They list:

• Paul Cruz III — Director and President.
• Marcelino Ruben Romero Jr. — Director and Chairman of the Board of Directors.
• Nicholas Roman Menchaca — Director and Treasurer.
• Gricelda Cruz — Secretary.

These are the roles recorded in the formation filing; subsequent appointments or changes require their own records. The filing expressly labels three individuals as directors and lists the Secretary separately. Corporate appointments do not establish scientific qualifications or scientific-review participation.

Corporate governance and editorial authority

The Board of Directors is distinct from the Scientific Advisory Board and from editorial review. The Chairman, officers, and any Executive Director act within the authority established by the corporate documents and documented appointments or delegations. No individual is assigned additional authority by this website.

Routine editorial and publication decisions must follow documented assignments, applicable policies, conflict rules, and the publication workflow. A website permission enables an action technically; it is not evidence of a corporate delegation or of scientific review. Corporate oversight does not make a scientific claim true.

The earlier term "Interim Editorial Review Committee" described an operational review function. It should not be read as an appointed board committee or as an independent, staffed review body. Its membership, scope, reporting relationship, and any delegated authority require documentation before those claims are made.

Governance documents and adoption status

Following incorporation, the Founding Charter and Governance Manual require reconciliation with the Articles, bylaws, and documented board actions. Earlier single-Owner provisions and Owner voting thresholds are legacy draft language, not a statement of current corporate authority.

This website correction is not adoption of bylaws, a conflict-of-interest policy, committee appointments, or a delegation of authority. Board-adoption dates and approved versions of those documents are not yet documented on this site. Corporate and editorial authority will be described from those records.

Reference: Arizona Revised Statutes § 10-3801.

Scientific and editorial independence

Scientific and editorial review is governed to preserve uncertainty, limitations, contradictions, provenance, and conflicts rather than optimize for commercial or promotional outcomes. Funding and conflicts are disclosed as verified institutional facts, not inferred from source counts or automated screening. Source review does not by itself approve a domain conclusion, a medical or safety claim, or a regulatory interpretation; each requires its own documented decision.

Evidence and claims boundary

The platform does not provide medical advice and does not automatically make medical, safety, efficacy, or regulatory conclusions.

Anonymous observations remain observational. They are never presented as controlled clinical evidence, and their presence does not establish causation, effectiveness, or safety.

What remains to be established

• Further organizational development and professional legal review following Arizona incorporation.
• A seated, publicly disclosed Scientific Advisory Board with conflict rules.
• External ethics/privacy determination and review of participant-facing policies.
• Published annual funding, conflict, correction, and governance reporting.

Public records and correction

Read the Public Charter, Methodology, Transparency policy, and Correction Log. Material errors or outdated status statements should be submitted through the public correction process.